Pacific Biosciences of California Inc
Most Recent
XBI Recovers from Its Slump
The SPDR S&P Biotech ETF (XBI) and the iShares Nasdaq Biotechnology ETF (IBB) were the top biotechnology ETFs last week, returning 5.3%, and 3.7%.
Pacific Biosciences of California Rose 67.63% on November 2
On November 2, Pacific Biosciences of California (PACB) closed at $7.56, which was 67.63% higher than its previous closing price.
Why Is Pacific Biosciences Stock Up ~6.2% Today?
Today, Pacific Biosciences of California (PACB) is trading at $5.16 per share, up ~6.17% from yesterday’s close of $4.86.
What’s behind Thermo Fisher’s Rumored Acquisition of Illumina?
On August 18, 2016, Illumina (ILMN) rose more than 3% amid rumors of Thermo Fisher Scientific (TMO) acquiring Illumina for $30 billion in an all-stock deal.
